2023 is expected to be a year of advancements in connected care supporting patients with chronic conditions and their care teams. Glooko CEO Russ Johannesson shares his outlook on trends in digital therapeutics, precision engagement, remote patient monitoring and clinical trial management.

Read More...

Smart insulin pens are a recent advancement making an impact on people living with diabetes. These connected pens can be used by anyone with the chronic condition that injects insulin and can sync with certain digital health apps, like Glooko, that store insulin, blood glucose, fitness and food data in one place.

Read More...

Sanofi formed a partnership with Glooko to support its vision of insulin-based therapies connected with glucose monitoring devices that simplify blood glucose management for people with diabetes.

Read More...